clinical trial · NCT06795165
Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
Eye Research Foundation, Inc.·phase4·completed·n = 24
BlepharitisMoxidectin 2 MG Oral TabletPlacebo
brief summary
A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
started
Feb 2, 2025
primary completion
Apr 28, 2025
completion
Jun 15, 2025
last updated
Aug 12, 2025
official title
A Single-center, Investigator-masked, Randomized, Placebo-controlled, Investigator-initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol